1. Home
  2. ZBH

as 11-15-2024 4:00pm EST

$
-
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Industrial Specialties

Nasdaq

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Founded: 1927 Country:
United States
United States
Employees: N/A City: WARSAW
Market Cap: 20.8B IPO Year: N/A
Target Price: $124.40 AVG Volume (30 days): 1.6M
Analyst Decision: Hold Number of Analysts: 22
Dividend Yield:
0.85%
Dividend Payout Frequency: Quarterly
EPS: 5.26 EPS Growth: 132.72
52 Week Low/High: $101.47 - $133.90 Next Earning Date: 10-30-2024
Revenue: $7,595,500,000 Revenue Growth: 4.35%
Revenue Growth (this year): 4.76% Revenue Growth (next year): 4.63%

ZBH Daily Stock ML Predictions

Share on Social Networks: